These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11008220)

  • 1. Candiduria in hospitalized patients: a review.
    Nucci M
    Braz J Infect Dis; 2000 Aug; 4(4):168-72. PubMed ID: 11008220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candiduria in hospital patients: a study prospective.
    Kobayashi CC; de Fernandes OF; Miranda KC; de Sousa ED; Silva Mdo R
    Mycopathologia; 2004 Jul; 158(1):49-52. PubMed ID: 15487320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole therapy for candiduria.
    Castiglia M; Fisher MA; Smego RA
    J Fam Pract; 1995 Dec; 41(6):536. PubMed ID: 7500056
    [No Abstract]   [Full Text] [Related]  

  • 4. Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group.
    Sobel JD; Kauffman CA; McKinsey D; Zervos M; Vazquez JA; Karchmer AW; Lee J; Thomas C; Panzer H; Dismukes WE
    Clin Infect Dis; 2000 Jan; 30(1):19-24. PubMed ID: 10619727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey.
    Fadda ME; Podda GS; Pisano MB; Deplano M; Cosentino S
    J Prev Med Hyg; 2008 Jun; 49(2):69-74. PubMed ID: 18847180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial candiduria: a review.
    Lundstrom T; Sobel J
    Clin Infect Dis; 2001 Jun; 32(11):1602-7. PubMed ID: 11340532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To treat or not to treat--critically ill patients with candiduria.
    Hollenbach E
    Mycoses; 2008 Sep; 51 Suppl 2():12-24. PubMed ID: 18721329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans.
    Harris AD; Castro J; Sheppard DC; Carmeli Y; Samore MH
    Clin Infect Dis; 1999 Oct; 29(4):926-8. PubMed ID: 10589912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current treatment strategies for disseminated candidiasis.
    Spellberg BJ; Filler SG; Edwards JE
    Clin Infect Dis; 2006 Jan; 42(2):244-51. PubMed ID: 16355336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    Charlier C; Hart E; Lefort A; Ribaud P; Dromer F; Denning DW; Lortholary O
    J Antimicrob Chemother; 2006 Mar; 57(3):384-410. PubMed ID: 16449304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular typing and fluconazole susceptibility of urinary Candida glabrata isolates from hospitalized patients.
    Schwab U; Chernomas F; Larcom L; Weems J
    Diagn Microbiol Infect Dis; 1997 Sep; 29(1):11-7. PubMed ID: 9350410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Emergency of fluconazole-resistant infections by Candida krusei and Candida glabrata in neutropenic patients].
    Piemonte P; Conte G; Flores C; Barahona O; Araos D; Alfaro J; Fardella P; Thompson L
    Rev Med Chil; 1996 Sep; 124(9):1149. PubMed ID: 9197032
    [No Abstract]   [Full Text] [Related]  

  • 16. Candida urinary tract infections--treatment.
    Fisher JF; Sobel JD; Kauffman CA; Newman CA
    Clin Infect Dis; 2011 May; 52 Suppl 6():S457-66. PubMed ID: 21498839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients.
    Bussaratid V; Tansupasawasdikul S; Simpson A; Pitisuttithum P; Phonrat B; Howe P; White NJ
    J Med Assoc Thai; 2002 Jul; 85(7):757-64. PubMed ID: 12296406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
    J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluconazole consumption on long-term trends in candidal ecology.
    Blot S; Janssens R; Claeys G; Hoste E; Buyle F; De Waele JJ; Peleman R; Vogelaers D; Vandewoude K
    J Antimicrob Chemother; 2006 Aug; 58(2):474-7. PubMed ID: 16757503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.
    Hope W; Morton A; Eisen DP
    J Hosp Infect; 2002 Jan; 50(1):56-65. PubMed ID: 11825053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.